Transforming growth factor beta2 haploinsufficient mice develop age-related nigrostriatal dopamine deficits

Neurobiology of Disease

Volumn 21, Issue 3, 2006, Pages 568-575

  Andrews, Zane B ^a,b   Zhao, Hua ^a   Frugier, Tony ^a,c   Meguro, Reiko ^a,d   Grattan, David R ^a   Koishi, Kyoko ^a   McLennan, Ian S ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LINCOLN UNIVERSITY   (New Zealand)

^d HIROSAKI UNIVERSITY   (Japan)

Author keywords

DOPAC; Dopamine; Monoamine oxidase B; MPTP; Parkinson's disease; Substantia nigra; Susceptibility genes; TGF 2

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 3,4 DIHYDROXYPHENYLACETIC ACID; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; NEUROTOXIN; TRANSFORMING GROWTH FACTOR BETA2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; MOUSE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RISK; STRIATONIGRAL DEGENERATION; SUBSTANTIA NIGRA;

AGE FACTORS; ANIMALS; CELL COUNT; DOPAMINE; HAPLOTYPES; IMMUNOHISTOCHEMISTRY; MICE; MPTP POISONING; NEURONS; POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUBSTANTIA NIGRA; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA2;

EID: 33244470664     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2005.09.001     Document Type: Article

References (37)

1. M. Abercrombie Estimation of nuclear populations from microtome sections Anat. Rec. 94 1946 239 247
2. Z.B. Andrews, I.C. Kokay, and D.R. Grattan Dissociation of prolactin secretion from tuberoinfundibular dopamine activity in late pregnant rats Endocrinology 142 2001 2719 2724
3. G.P. Boivin, J.R. Molina, I. Ormsby, G. Stemmermann, and T. Doetschman Gastric lesions in transforming growth factor beta-1 heterozygous mice Lab. Invest. 74 1996 513 518
4. P. Carmeliet, V. Ferreira, G. Breier, S. Pollefeyt, L. Kieckens, M. Gertsenstein, M. Fahrig, A. Vandenhoeck, K. Harpal, C. Eberhardt, C. Declercq, J. Pawling, L. Moons, D. Collen, W. Risau, and A. Nagy Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele Nature 380 1996 435 439
5. W. Dauer, and S. Przedborski Parkinson's disease: mechanisms and models Neuron 39 2003 889 909
6. W.A. Day, K. Koishi, and I.S. McLennan Transforming growth factor beta 1 may regulate the stability of mature myelin sheaths Exp. Neurol. 284 2003 857 864
7. W.A. Day, K. Koishi, H. Nukuda, and I.S. McLennan Transforming growth factor beta2 causes an acute improvement in the motor performance of transgenic ALS mice Neurobiol. Dis. 19 2005 323 330
8. N. Dunker, and K. Krieglstein TGFbeta2 (-/-) TGFbeta3 (-/-) double knockout mice display severe midline fusion defects and early embryonic lethality Anat. Embryol. 206 2002 73 83
9. L.M. Farkas, N. Dunker, E. Roussa, K. Unsicker, and K. Krieglstein Development of midbrain dopaminergic neurons in vitro and in vivo J. Neurosci. 23 2003 5178 5186
10. K.C. Flanders, R.F. Ren, and C.F. Lippa Transforming growth factor-betas in neurodegenerative disease Prog. Neurobiol. 54 1998 71 85
11. T. Foltynie, C.E. Brayne, T.W. Robbins, and R.A. Barker The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study Brain 127 2004 550 560
12. T. Foltynie, S.G. Lewis, T.E. Goldberg, A.D. Blackwell, B.S. Kolachana, D.R. Weinberger, T.W. Robbins, and R.A. Barker The BDNF Val(66)Met polymorphism has a gender specific influence on planning ability in Parkinson's disease J. Neurol. 252 2005 833 838
13. J. Grimsby, M. Toth, K. Chen, T. Kumazawa, L. Klaidman, J.D. Adams, F. Karoum, J. Gal, and J.C. Shih Increased stress response and beta- phenylethylamine in MAOB-deficient mice Nat. Genet. 17 1997 206 210
14. H.J. Gundersen, P. Bagger, T.F. Bendtsen, S.M. Evans, L. Korbo, N. Marcussen, A. Moller, K. Nielsen, J.R. Nyengaard, B. Pakkenberg, F.B. Sorensen, A. Vesterby, and M.J. West The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis Acta Pathol. Microbiol. Immunol. Scand. 96 1988 857 881
15. Y. Jiang, I.S. McLennan, K. Koishi, and I.A. Hendry TGF-beta2 is anterogradely and retrogradely transported in motoneurons and up-regulated after nerve injury Neuroscience 97 2000 735 742
16. V. Kaartinen, J.W. Voncken, C. Shuler, D. Warburton, D. Bu, N. Heisterkamp, and J. Groffen Abnormal lung development and cleft palate in mice lacking TGF-beta3 indicates defects of epithelial-mesenchymal interaction Nat. Genet. 11 1995 415 421
17. K. Krieglstein, and K. Unsicker Transforming growth factor-beta promotes survival of midbrain dopaminergic neurons and protects them against n-methyl-4-phenylpyridium ion toxicity Neuroscience 63 1994 1189 1196
18. K. Krieglstein, C. Suter-Crazzolara, W.H. Fischer, and K. Unsicker TGF-b superfamily members promote survival of midbrain dopaminergic neurons and protect them against MPP+ toxicity EMBO J. 14 1995 736 742
19. A.B. Kulkarni, C.G. Huh, D. Becker, A. Geiser, M. Lyght, K.C. Flanders, A.B. Roberts, M.B. Sporn, J.M. Ward, and S. Karlsson Transforming growth factor-beta1 null mutation in mice causes excessive inflammatory response and early death Proc. Natl. Acad. Sci. U. S. A. 90 1993 770 774
20. D. Lambrechts, E. Storkebaum, M. Morimoto, J. Del-Favero, F. Desmet, S.L. Marklund, S. Wyns, V. Thijs, J. Andersson, I. van Marion, A. Al-Chalabi, S. Bornes, R. Musson, V. Hansen, L. Beckman, R. Adolfsson, H.S. Pall, H. Prats, S. Vermeire, P. Rutgeerts, S. Katayama, T. Awata, N. Leigh, L. Lang-Lazdunski, M. Dewerchin, C. Shaw, L. Moons, R. Vlietinck, K.E. Morrison, W. Robberecht, C. Van Broeckhoven, D. Collen, P.M. Andersen, and P. Carmeliet VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death Nat. Genet. 34 2003 383 394
21. I.S. McLennan, and K. Koishi The transforming growth factor-betas: multifaceted regulators of the development and maintenance of skeletal muscles, motoneurons and Schwann cells Int. J. Dev. Biol. 46 2002 559 567
22. I.S. McLennan, and K. Koishi Fetal and maternal transforming growth factor-beta1 may combine to maintain pregnancy in mice Biol. Reprod. 70 2004 1614 1618
23. I.S. McLennan, and R.E. Macdonald Prostaglandin synthetase and prostacyclin synthetase in mature rat skeletal muscles: immunohistochemical localisation to arterioles, tendons and connective tissues J. Anat. 178 1991 243 253
24. I.S. McLennan, and J. Taylor-Jeffs The use of sodium lamps to brightly illuminate mouse houses during their dark phases Lab. Anim. 38 2004 1 9
25. I.S. McLennan, K. Koishi, M. Zhang, and N. Murakami The non-synaptic expression of transforming growth factor-beta 2 is neurally regulated and varies between skeletal muscle fibre types Neuroscience 87 1998 845 853
26. M. Mogi, M. Harada, T. Kondo, H. Narabayashi, P. Riederer, and T. Nagatsu Transforming growth factor-beta 1 levels are elevated in the striatum and in ventricular cerebrospinal fluid in Parkinson's disease Neurosci. Lett. 193 1995 129 132
27. B. Oosthuyse, L. Moons, E. Storkebaum, H. Beck, D. Nuyens, K. Brusselmans, J. Van Dorpe, P. Hellings, M. Gorselink, S. Heymans, G. Theilmeier, M. Dewerchin, V. Laudenbach, P. Vermylen, H. Raat, T. Acker, V. Vleminckx, L. Van Den Bosch, N. Cashman, H. Fujisawa, M.R. Drost, R. Sciot, F. Bruyninckx, D.J. Hicklin, C. Ince, P. Gressens, F. Lupu, K.H. Plate, W. Robberecht, J.M. Herbert, D. Collen, and P. Carmeliet Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration Nat. Genet. 28 2001 131 138
28. A. Parsian, R. Sinha, B. Racette, J.H. Zhao, and J.S. Perlmutter Association of a variation in the promoter region of the brain-derived neurotrophic factor gene with familial Parkinson's disease Parkinsonism Relat. Disord. 10 2004 213 219
29. L. Pietri, M. Bloch-Faure, M.F. Belair, L.P. Sanford, T. Doetschman, J. Menard, P. Bruneval, and P. Meneton Altered renin synthesis and secretion in the kidneys of heterozygous mice with a null mutation in the TGF-beta(2) gene Exp. Nephrol. 10 2002 374 382
30. K.T. Poulsen, M.P. Armanini, R.D. Klein, M.A. Hynes, H.S. Phillips, and A. Rosenthal TGF beta2 and TGF beta3 are potent survival factors for midbrain dopaminergic neurons Neuron 13 1994 1245 1252
31. A.B. Roberts, K.C. Flanders, U.I. Heine, S. Jakowlew, P. Kondaiah, S.J. Kim, and M.B. Sporn Transforming growth factor-beta-Multifunctional regulator of differentiation and development Philos. Trans. R. Soc. London 327B 1990 145 154
32. A. Sanchez-Capelo, P. Colin, B. Guibert, N.F. Biguet, and J. Mallet Transforming growth factor beta1 overexpression in the nigrostriatal system increases the dopaminergic deficit of MPTP mice Mol. Cell. Neurosci. 23 2003 614 625
33. L.P. Sanford, I. Ormsby, A.C. Gittenberger-de Groot, H. Sariola, R. Friedman, G.P. Boivin, E.L. Cardell, and T. Doetschman TGF-beta2 knockout mice have multiple developmental defects that are non-overlapping with other TGF-beta knockout phenotypes Development 124 1997 2659 2670
34. R.J. Smeyne, and V. Jackson-Lewis The MPTP model of Parkinson's disease Mol. Brain Res. 134 2005 57 66
35. K.L. Stenvers, M.L. Tursky, K.W. Harder, N. Kountouri, S. Amatayakul-Chantler, D. Grail, C. Small, R.A. Weinberg, A.M. Sizeland, and H.J. Zhu Heart and liver defects and reduced transforming growth factor beta2 sensitivity in transforming growth factor beta type III receptor-deficient embryos Mol. Cell. Biol. 23 2003 4371 4385
36. M.P. Vawter, O. Dillon-Carter, W.W. Tourtellotte, P. Carvey, and W.J. Freed TGFbeta1 and TGFbeta2 concentrations are elevated in Parkinson's disease in ventricular cerebrospinal fluid Exp. Neurol. 142 1996 313 322
37. A.K. Wright, J.F. Atherton, L. Norrie, and G.W. Arbuthnott Death of dopaminergic neurones in the rat substantia nigra can be induced by damage to globus pallidus Eur. J. Neurosci. 20 2004 1737 1744